418 related articles for article (PubMed ID: 15817906)
21. CRH stimulation improves
Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
[TBL] [Abstract][Full Text] [Related]
22. Carcinoid tumors of the thymus and Cushing's syndrome: Clinicopathologic features and current best evidence regarding the cell of origin of these unusual neoplasms.
Walts AE; Frye J; Engman DM; Marchevsky AM
Ann Diagn Pathol; 2019 Feb; 38():71-79. PubMed ID: 30502716
[TBL] [Abstract][Full Text] [Related]
23. Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling.
Burman P; Lethagen A; Ivancev K; Johansson L; Sundin A
Eur J Endocrinol; 2008 Oct; 159(4):483-8. PubMed ID: 18625689
[TBL] [Abstract][Full Text] [Related]
24. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
[TBL] [Abstract][Full Text] [Related]
25. Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.
Zhou J; Ju H; Zhu L; Pan Y; Lv J; Zhang Y
Nucl Med Commun; 2019 May; 40(5):539-544. PubMed ID: 30973841
[TBL] [Abstract][Full Text] [Related]
26. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
27. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
Schteingart DE; Lloyd RV; Akil H; Chandler WF; Ibarra-Perez G; Rosen SG; Ogletree R
J Clin Endocrinol Metab; 1986 Sep; 63(3):770-5. PubMed ID: 3525603
[TBL] [Abstract][Full Text] [Related]
28. Value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in diagnosis and localization of Cushing's disease.
Xin C; Rui-xue C; Hui P; Tao Y; Hui-Juan Z; Fang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):107-10. PubMed ID: 21529433
[TBL] [Abstract][Full Text] [Related]
29. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome.
Nomura C; Nakano Y; Tanaka T; Shima KR; Kometani M; Kanamori T; Ikeda H; Takeshita Y; Yoneda T; Takamura T
Intern Med; 2022 Dec; 61(24):3693-3698. PubMed ID: 35650126
[TBL] [Abstract][Full Text] [Related]
31. Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.
Moraes AB; Taboada GF; Carneiro MP; Neto LV; Wildemberg LE; Madi K; Domingues RC; Gadelha MR
Pituitary; 2009; 12(4):380-3. PubMed ID: 18459046
[TBL] [Abstract][Full Text] [Related]
32. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine carcinoma of the thyroid causing adrenocorticotrophic hormone-dependent Cushing's syndrome.
Dutta D; Mukhopadhyay S; Maisnam I; Ghosh S; Mukhopadhyay P; Chowdhury S
Thyroid; 2013 Jan; 23(1):120-3. PubMed ID: 23140512
[TBL] [Abstract][Full Text] [Related]
34. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
35. [Ectopic ACTH- or CRH-secreting tumors in Cushing's syndrome].
Saeger W; Reincke M; Scholz GH; Lüdecke DK
Zentralbl Pathol; 1993 Jun; 139(2):157-63. PubMed ID: 8396419
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic Cushing syndrome, case-series and review of the literature.
Deldycke A; Haenebalcke C; Taes Y
Acta Clin Belg; 2018 Aug; 73(4):298-304. PubMed ID: 28895465
[TBL] [Abstract][Full Text] [Related]
37. [Thymic carcinoid tumor causing paraneoplastic Cushing syndrome. Diagnostic value of double-labelled tomoscintigraphy].
Matejka G; Toubeau M; Bernard A; Belleville Y; Vaillant G; Brun JM
Presse Med; 1996 Sep; 25(26):1201-2. PubMed ID: 8949624
[TBL] [Abstract][Full Text] [Related]
38. Cushing's syndrome caused by ectopic corticotropin secretion by multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type.
Ozbey N; Bozbora A; Kalayci G; Kapran Y; Yilmazbayhan D; Dizdaroglu F; Orhan Y; Sencer E; Molvalilar S
J Endocrinol Invest; 2000 Sep; 23(8):536-41. PubMed ID: 11021771
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling.
Doppman JL; Pass HI; Nieman LK; Miller DL; Chang R; Cutler GB; Chrousos GP; Jaffe GS; Norton JA
Radiology; 1992 Jul; 184(1):71-4. PubMed ID: 1319078
[TBL] [Abstract][Full Text] [Related]
40. Roentgenologic diagnosis of primary corticotropin-producing carcinoid tumors of the mediastinum.
Brown LR; Aughenbaugh GL; Wick MR; Baker BA; Salassa RM
Radiology; 1982 Jan; 142(1):143-8. PubMed ID: 6273965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
